Tenet price target raised to $64, guidance conservative, says Mizuho Mizuho raised Tenet's price target to $64 from $59 following the Q2 beat and said guidance is likely conservative. The firm reiterates its buy rating based on solid earnings visibility, health reform earnings upside, M&A, and Confier business and outpatient growth. Shares are Buy rated.
UBS to hold a conference Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link